Extensions to amino acid description

Molecular Diversity

Volumn 14, Issue 4, 2010, Pages 709-718

  Gottfries, Johan ^a   Eriksson, Lennart ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b Umetrics AB   (Sweden)

Author keywords

Amino acid description; Flexibility; OPLS O2PLS; Peptide; Rigidity

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; 2 AMINOBUTYRIC ACID; 3 (1 NAPHTHYL)ALANINE; 3 (2 NAPHTHYL)ALANINE; 3,4 DEHYDROPROLINE; 4 HYDROXYPROLYINE; ALANINE; ALLOISOLEUCINE; ALPHA METHYLLEUCINE; AMINO ACID; AMINOOCTANOIC ACID; ARGININE; ASPARAGINE; CYSTEINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; SYNTHETIC PEPTIDE; THREONINE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SEQUENCE; ARTICLE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; AMINO ACIDS; COMPUTATIONAL BIOLOGY; PEPTIDES; PRINCIPAL COMPONENT ANALYSIS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RELATIVE VALUE SCALES; VALIDATION STUDIES AS TOPIC;

EID: 78650175434     PISSN: 13811991     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11030-009-9204-2     Document Type: Article

References (27)

1. REW Hancock HG Sahl 2006 Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies Nat Biotechnol 24 1551 1557 10.1038/nbt1267 1:CAS:528:DC%2BD28Xht12gtbvM 10.1038/nbt1267 17160061 (Pubitemid 44967479)
2. SH Burg MS Bijker MJP Welters R Offringa CJM Melief 2006 Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy Adv Drug Deliv Rev 58 916 930 10.1016/j.addr.2005.11.003 10.1016/j.addr.2005.11.003 16979788 (Pubitemid 44709262)
3. J Nurbo AK Roos D Muthas E Wahlström DJ Ericsson T Lundstedt T Unge A Karlén 2007 Design, synthesis and evaluation of peptide inhibitors of Mycobacterium tuberculosis ribonucleotide reductase J Pept Sci 13 822 832 10.1002/psc.906 1:CAS:528:DC%2BD1cXkslylsw%3D%3D 10.1002/psc.906 17918768 (Pubitemid 350303220)
4. D Muthas PM Lek J Nurbo A Karlén T Lundstedt 2007 Focused hierarchical design of peptide libraries-follow the lead J Chemom 21 486 495 10.1002/cem.1069 1:CAS:528:DC%2BD2sXhtlKktrjN 10.1002/cem.1069
5. A Tavassoli Q Lu J Gam H Pan SJ Benkovic SN Cohen 2008 Inhibition of HIV budding by a genetically selected cyclic peptide targeting the GAG-TSG101 interaction ACS Chem Biol 3 757 764 10.1021/cb800193n 1:CAS:528: DC%2BD1cXhsFSqsrbN 10.1021/cb800193n 19053244
6. J Gottfries 2006 The drug designers guide to selectivity Chemom Intell Lab Syst 83 148 156 10.1016/j.chemolab.2006.03.003 1:CAS:528: DC%2BD28XptlSlt7Y%3D 10.1016/j.chemolab.2006.03.003 (Pubitemid 44348909)
7. HP Kalofonos PD Grivas 2006 Monoclonal antibodies in the management of solid tumors Curr Top Med Chem 6 1687 1705 10.2174/156802606778194208 1:CAS:528:DC%2BD28XhtVCgsLjL 10.2174/156802606778194208 17017951 (Pubitemid 44323057)
8. S Danese S Semerano A Armuzzi A Papa A Gasbarrini 2006 Biological therapies for IBD: research drives clinic Mini Rev Med Chem 6 771 784 1:CAS:528:DC%2BD28XlvFCnsLw%3D 10.2174/138955706777698624 16842127 (Pubitemid 44027730)
9. S Runge H Thogersen K Madsen J Lau R Rudolph 2008 Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain J Biol Chem 283 11340 11347 10.1074/jbc.M708740200 1:CAS:528:DC%2BD1cXkvVSgtr4%3D 10.1074/jbc.M708740200 18287102
10. A Plaza G Bifulco JL Keffer JR Lloyd HL Baker CA Bewley 2009 Celebesides A-C and theopapuamides B-D, depsipeptides from an Indonesian sponge that inhibit HIV-1 entry J Org Chem 74 504 512 10.1021/jo802232u 1:CAS:528: DC%2BD1cXhsV2rtLvO 10.1021/jo802232u 19072692
11. AC Couffic-Hoarau AM Aubertin M Bousstta S Schmidt JA Fehrentz J Martinez M Vert 2009 Peptide-poly(L-lysine citramide) conjugates and their in vitro anti-HIV behaviour Macromolecules 10 865 876 10.1021/bm801376v
12. M Lapinsh P Prusis T Lundstedt JE Wikberg 2002 Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands Mol Pharmacol 61 1465 1475 1:CAS:528:DC%2BD38XksVWrtb4%3D 10.1124/mol.61.6.1465 12021408 (Pubitemid 34578132)
13. S Hellberg M Sjöström B Skagerberg S Wold 1987 Peptide QSAR, a multivariate approach J Med Chem 30 1126 1135 1:CAS:528:DyaL2sXktFOhsLY%3D 10.1021/jm00390a003 3599020
14. J Jonsson L Eriksson S Hellberg M Sjöström S Wold 1989 Multivariate parametrization of 55 coded and non-coded amino acids Quant Struct Act Relat 8 204 209 1:CAS:528:DyaK3cXitFOmsLY%3D 10.1002/qsar.19890080303
15. M Sandberg L Eriksson J Jonsson M Sjöström S Wold 1998 New chemical descriptors relevant for design of biologically active peptides. A multivariate characterization of 87 amino acids J Med Chem 41 2481 2491 1:CAS:528:DyaK1cXktlShuro%3D 10.1021/jm9700575 9651153 (Pubitemid 28321898)
16. A Ikai 2005 Local rigidity of a protein molecule Biophys Chem 116 187 191 10.1016/j.bpc.2005.04.003 1:CAS:528:DC%2BD2MXmt1ehs7g%3D 10.1016/j.bpc.2005.04. 003 15882923 (Pubitemid 40962445)
17. A Schlessinger B Rost 2005 Protein flexibility and rigidity predicted from sequence Proteins Struct Funct Bioinf 61 115 126 10.1002/prot.20587 1:CAS:528:DC%2BD2MXhtVSjsL7N 10.1002/prot.20587 (Pubitemid 41262922)
18. NJ de Mol MI Catalina FJ Dekker MJE Fischer AJR Heck RMJ Liskamp 2005 Protein flexibility and ligand rigidity: a thermodynamic and kinetic study of ITAM-based ligand binding to Syk tandem SH2 Chem bio chem 6 2261 2270 10.1002/cbic.200500141 16252296
19. Jackson JE (1991) A user's guide to principal components. Wiley, New York
20. J Trygg S Wold 2002 Orthogonal projections to latent structures (OPLS) J Chemom 16 119 128 10.1002/cem.695 1:CAS:528:DC%2BD38XitFClu7c%3D 10.1002/cem.695
21. J Trygg S Wold 2003 O2PLS, a two-block (X-Y) latent variable regression (LVR) method with an integral OSC filter J Chemom 17 53 64 10.1002/cem.775 1:CAS:528:DC%2BD3sXitFWms70%3D 10.1002/cem.775
22. S Hellberg L Eriksson J Jonsson F Lindgren M Sjöström B Skagerberg S Wold P Andrews 1991 Minimum analogue peptide sets (MAPS) for quantitative structure-activity relationships Int J Pept Protein Res 37 414 424 1:CAS:528:DyaK38XhsFeguw%3D%3D 10.1111/j.1399-3011.1991.tb00756.x 1917297
23. Sjöström M, Eriksson L, Hellberg S, Jonsson J, Skagerberg B, Wold S (1989) Peptide QSARs: PLS modelling and design in principal properties. In: Fauchère JL (ed) QSAR-quantitative structure-activity relationships in drug design. Proceedings of the 7th European symposium on QSAR, Sept 1988, Interlaken, Switzerland. Alan R. Liss, Inc, New York, pp 131-134
24. IM Olsson J Gottfries S Wold 2004 D-optimal onion designs in statistical molecular modelling Chemom Intell Lab Syst 73 37 46 10.1016/j.chemolab.2004.04. 001 1:CAS:528:DC%2BD2cXntlSjsbg%3D 10.1016/j.chemolab.2004.04.001 (Pubitemid 39198946)
25. IM Olsson J Gottfries S Wold 2004 Controlling coverage of D-optimal onion designs and selections J Chemom 18 548 557 10.1002/cem.901 1:CAS:528: DC%2BD2MXhtFyjsbzP 10.1002/cem.901 (Pubitemid 40830845)
26. A Larsson SMC Johansson JS Pinkner SJ Hultgren F Almqvist J Kihlberg A Linusson 2005 Multivariate design, synthesis, and biological evaluation of peptide inhibitors of FimC/FimH protein-protein interactions in uropathogenic Escherichia coli J Med Chem 48 935 945 10.1038/nrmicro1818 1:CAS:528: DC%2BD2MXosFWmsQ%3D%3D 10.1021/jm040818l 15715464
27. TI Oprea J Gottfries 2001 Chemography: the art of navigating in chemical space J Comb Chem 3 157 166 10.1021/cc0000388 1:CAS:528:DC%2BD3MXhtFams78%3D 10.1021/cc0000388 11300855 (Pubitemid 33614499)